Tocopherol Ester Nasal Composition for Allergic Rhinitis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for allergic rhinitis often have side effects and poor patient compliance, leading to risks of disease diffusion to other allergens and allergic asthma.
Innovation Solution
A topical composition containing an ester of alpha-tocopherol, such as alpha-tocopheryl acetate or alpha-tocopheryl linoleate, combined with an oily vehicle like hydrogenated polydecene, for direct application to the nasal mucosa, which forms a protective film or chemically neutralizes allergens, reducing symptoms without systemic side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antihistamines and corticosteroids are used for treatment of allergic rhinitis, then symptom relief is achieved, but side effects occur and patient compliance decreases
Solution Approach 1:
The patent extracts and eliminates the harmful side effects associated with conventional antihistamines and corticosteroids by using a purely natural composition of tocopherol esters and plant oils, which provides effective symptom relief without the adverse reactions that limit patient compliance
Solution Approach 2:
The invention uses a composite formulation combining multiple tocopherol esters (alpha-tocopheryl acetate, gamma-tocopheryl acetate) with plant-derived oils (olive oil, sunflower oil, hemp seed oil) to create a synergistic composition that maintains treatment effectiveness while avoiding the side effects of synthetic pharmaceuticals
2Reliability
If conventional medications are used for allergic rhinitis, then some symptom relief is provided, but patient compliance remains inadequate leading to disease diffusion
Solution Approach 1:
The patent employs a simple, natural composition that can be easily applied topically to the nasal mucosa, replacing complex pharmaceutical regimens with a user-friendly formulation that patients are more willing to use consistently, thereby preventing disease diffusion through improved compliance
3Object-generated harmful factors
If tocopherol and vitamin E are used alone, then antioxidant effects are provided, but insufficient therapeutic effect is achieved for allergic rhinitis
Solution Approach 1:
The patent merges tocopherol esters with plant-derived oils containing complementary active substances (flavonoids, phenolic compounds, essential oils) to create a synergistic composition where the combined therapeutic effect exceeds the sum of individual components, achieving effective treatment of allergic rhinitis
Solution Approach 2:
The invention creates a composite material combining tocopherol esters with plant oils rich in bioactive compounds, where the interaction between different substances produces enhanced anti-inflammatory, antiallergic, and protective effects that neither component achieves alone
4Stability of the object's composition
If topical compositions contain emulsifiers and carriers, then stability is improved, but the composition becomes more complex and less natural
Solution Approach 1:
The patent uses plant-derived oils that naturally serve as both carriers and stabilizing agents for the tocopherol esters, eliminating the need for additional emulsifiers and synthetic carriers. The plant oils' natural properties provide sufficient stability while maintaining a simple, natural formulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces nasal obstruction, secretion, and improves sleep and quality of life, allowing patients to reduce or discontinue antihistamines and corticosteroids, with high patient adherence and willingness to continue treatment.
Implementation Method 1
a compound that inhibits reactive oxygen species... tocopherol
Implementation Method 2
for topical application... direct application to the nasal mucosa, which forms a protective film
Data Source
AI summary
Composition for topical application, for use in the prevention and treatment of allergic rhinitis, consisting ofan ester of alpha-tocopherol selected from the group consisting of tocopheryl acetate, n-propionate and linoleate, and an oily vehicle selected from the group consisting of hydrogenated polyisobutene, hydrogenated polydecene and mixtures of hydrogenated polyisobutene and/or hydrogenated polydecene with hydrogenated polyolefins, in particular hydrogenated C6-C14 hydrogenated polyolefins, Caprylic/Capric Triglyceride, Olus Oil, Adansonia Digitata Oil, Adansonia Digitata Seed Oil, Coco-Caprylate/Caprate, Olive Squalane, Olive Squalene, Sunflower (Heliantus Annus) Seed Oil, Coco-Caprylate, Isononyl Isononanoate, Cyclopentasiloxane, and mixtures thereof.